Kionex Related Published Studies
Well-designed clinical trials related to Kionex (Sodium Polystyrene Sulfonate)
Efficacy of the cation exchange resin, sodium polystyrene sulfonate, to decrease iron absorption. [2000]
Effect of three laxatives and a cation exchange resin on fecal sodium and potassium excretion. [1995.03]
Effect of sodium polystyrene sulfonate on lithium bioavailability. [1992.11]
Lithium absorption prevented by sodium polystyrene sulfonate in volunteers. [1992.11]
Well-designed clinical trials possibly related to Kionex (Sodium Polystyrene Sulfonate)
Management of yellow oleander poisoning. [2009.03]
Fourteen-day safety and acceptability study of the universal placebo gel. [2007.02]
Single and multiple exposure tolerance study of polystyrene sulfonate gel: a phase I safety and colposcopy study. [2004.07]
Potassium-adsorption filter for RBC transfusion: a phase III clinical trial. [2000.12]
Glucose and insulin infusion versus kayexalate for the early treatment of non-oliguric hyperkalemia in very-low-birth-weight infants. [1999.09]
Other research related to Kionex (Sodium Polystyrene Sulfonate)
Surface orientation of phenyl groups in poly(sodium 4-styrenesulfonate) and in poly(sodium 4-styrenesulfonate):poly(3,4-ethylenedioxythiophene) mixture examined by sum frequency generation vibrational spectroscopy. [2010.09.07]
Successful treatment of lithium toxicity with sodium polystyrene sulfonate: a retrospective cohort study. [2010.01]
Ileocolic perforation secondary to sodium polystyrene sulfonate in sorbitol use: a case report. [2009.10]
[Digestive adverse effects due to sodium polystyrene sulfonate (Kayexalate) in dialysis patients] [2009.06]
Intestinal necrosis due to sodium polystyrene sulfonate (Kayexalate) in sorbitol. [2009.05]
Effect of the charge on the morphology of sodium salt form of the randomly sulfonated polystyrene ionomer cast onto silicon wafers. [2007.11]
Rectal stenosis caused by foreign body reaction to sodium polystyrene sulfonate crystals (Kayexalate). [2007.06]
Necrotizing enterocolitis in a 850 gram infant receiving sorbitol-free sodium polystyrene sulfonate (Kayexalate): clinical and histopathologic findings. [2007.04]
Development and characterization of bioadhesive vaginal films of sodium polystyrene sulfonate (PSS), a novel contraceptive antimicrobial agent. [2005.04]
Hypernatraemia induced by sodium polystyrene sulphonate (Kayexalate) in two extremely low birth weight newborns. [2004.03]
Poly(sodium 4-styrene sulfonate): evaluation of a topical microbicide gel against herpes simplex virus type 2 and Chlamydia trachomatis infections in mice. [2003.08]
Efficacy and safety of a new vaginal contraceptive antimicrobial formulation containing high molecular weight poly(sodium 4-styrenesulfonate). [2002.04]
[Colonic necrosis caused by sodium polystyrene (kayexalate) in hemodialysis: myth or reality? Two case reports] [2002]
Upper gastrointestinal tract injury in patients receiving kayexalate (sodium polystyrene sulfonate) in sorbitol: clinical, endoscopic, and histopathologic findings. [2001.05]
Poly(sodium 4-styrene sulfonate): an effective candidate topical antimicrobial for the prevention of sexually transmitted diseases. [2000.02]
Mineral content of infant formula after treatment with sodium polystyrene sulfonate or calcium polystyrene sulfonate. [1998]
Use of sodium polystyrene sulfonate for reduction of plasma lithium concentrations after chronic lithium dosing in mice. [1998]
[Sodium polystyrene sulfonate (Resonium A) as possible cause of rectal blood loss] [1997.11.01]
[Thrombocytopenia associated with sodium polystyrene sulfonate] [1997.11]
Kayexalate (sodium polystyrene sulphonate) in sorbitol associated with intestinal necrosis in uremic patients. [1997.10]
Enhancement of lithium elimination by multiple-dose sodium polystyrene sulfonate. [1997.03]
Necrosis of the gastrointestinal tract in uremic patients as a result of sodium polystyrene sulfonate (Kayexalate) in sorbitol: an underrecognized condition. [1997.01]
Other possibly related research studies
Pathological effects of drugs on the gastrointestinal tract: a review. [2007.04]
Role of seminal plasma in the anti-HIV-1 activity of candidate microbicides. [2006.10.16]
The management of tumor lysis syndrome. [2006.08]
In vitro-reassembled plant virus-like particles for loading of polyacids. [2006.09]
Salt wasting disorder in the newborn. [2006.01]
Multilayer microcapsules as anti-cancer drug delivery vehicle: deposition, Sustained release, and in vitro bioactivity. [2005.12.15]
Functional assessment of microencapsulated porcine islets with agarose polystyrene sulfonic acid in vitro and in xenotransplantation. [2005.10]
Protection of mammalian cell used in biosensors by coating with a polyelectrolyte shell. [2006.02.15]
Effects of candidate vaginally-applied microbicide compounds on innate immune cells. [2005.08]
Inhibition of Neisseria gonorrhoeae genital tract infection by leading-candidate topical microbicides in a mouse model. [2004.02.01]
Benefits and risks of calcium resonium therapy in hyperkalaemic preterm infants. [2003]
Intestinal necrosis following Calcium Resonium-sorbitol administration in a premature uraemic infant. [2002.10]
A semi-empirical approach to the modeling of the electrophoretic mobility in free solution: application to polystyrenesulfonates of various sulfonation rates. [2000.11]
Electrocardiographic manifestations of hyperkalemia. [2000.10]
Pseudohypoaldosteronism: mineralocorticoid unresponsiveness syndrome. [2000.08]
Acute abdomen with colonic necrosis induced by Kayexalate-sorbitol. [2000.05]
The management of hyperkalaemia in the emergency department. [2000.05]
The promise of public/private sector collaboration in the development of vaginal microbicides. [1999.12]
Hyperkalemia risks in hemodialysed patients consuming fluoride-rich water. [1999.03]
The effects of Pain-Free Desensitizer on dentine permeability and tubule occlusion over time, in vitro. [1998.11]
Effect of single dose resin-cathartic therapy on serum potassium concentration in patients with end-stage renal disease. [1998.10]
Effectiveness of ciprofloxacin-polystyrene sulfonate (PSS), ciprofloxacin and ofloxacin in a Staphylococcus keratitis model. [1998.08]
Microparticle resins as a potential nasal drug delivery system for insulin. [1998.03.02]
Enhancement of immune response to intranasal influenza HA vaccine by microparticle resin. [1998.04]
Tests of vaginal microbicides in the mouse genital herpes model. [1997.11]
Combined gastric and ileocecal toxicity (serpiginous ulcers) after oral kayexalate in sorbital therapy. [1997.07]
Hypocalcemia and hypomagnesemia after ibuprofen overdose. [1997.04]
[Effect of ion exchange resins on the composition of milk] [1997]
Methods used to decrease lithium absorption or enhance elimination. [1997]
Salbutamol versus cation-exchange resin (kayexalate) for the treatment of nonoliguric hyperkalemia in preterm infants. [2008.03]
Linear assemblies of magnetic nanoparticles as MRI contrast agents. [2008.04.02]
Dose-response to a jelly preparation of calcium polystyrene sulfonate in patients with hyperkalemia--changes in serum potassium levels with or without a RAAS inhibitor. [2007.12]
Successful treatment of a colonic ulcer penetrating the urinary bladder caused by the administration of calcium polystyrene sulfonate and sorbitol. [2007.10]
Structural study of coacervation in protein-polyelectrolyte complexes. [2008.09]
Ultrafiltration separation of aquatic natural organic matter: chemical probes for quality assurance. [2009.08]
ECG manifestations of multiple electrolyte imbalance: peaked T wave to P wave ("tee-pee sign"). [2009.04]
Preparation of functional aptamer films using layer-by-layer self-assembly. [2009.05.11]
Positive intraluminal bowel contrast on computed tomography following oral ingestion of kayexelate. [2008.12]
Colonic necrosis due to oral kayexalate in a critically-ill patient. [2009.04]
[Secondary hyperkalaemic acute flaccid tetraplegia] [2009.04]
Understanding medication errors: discussion of a case involving a urinary catheter implicated in a wrong route error. [2008.12]
Medication-induced upper gastrointestinal tract injury. [2009.02]
Reversible polyelectrolyte capsules as carriers for protein delivery. [2010.07.01]
[Calcium polystyrene sulfonate induced colonic necrosis in patient with chronic kidney disease] [2010.04]
Ion-exchange resins for the treatment of hyperkalemia: are they safe and effective? [2010.05]
Iontophoretic transport of charged macromolecules across human sclera. [2010.03.30]
Colonic mucosal necrosis following administration of calcium polystryrene sulfonate (Kalimate) in a uremic patient. [2009.12]
Biofouling control using microparticles carrying a biocide. [2010]
Polyelectrolyte mediated formation of hydroxyapatite microspheres of controlled size and hierarchical structure. [2009.11.01]
Absorption of 10-hydroxycamptothecin on Fe3O4 magnetite nanoparticles with layer-by-layer self-assembly and drug release response. [2011.03.28]
Templated ultrathin polyelectrolyte microreservoir for delivery of bovine serum albumin: fabrication and performance evaluation. [2011.03]
Cell adhesive behavior on thin polyelectrolyte multilayers: cells attempt to achieve homeostasis of its adhesion energy. [2010.08.03]
|
